Can a phone app help lower your cholesterol? new study aims to find out

NCT ID NCT07478887

First seen Mar 24, 2026

Summary

This study tests a digital health program called Corrie Lipids in about 1,000 adults with high LDL cholesterol and heart disease risk. The program includes a smartphone app for tracking cholesterol, medication reminders, and education, plus training for doctors to improve cholesterol management. Researchers want to see if the program helps more people reach their LDL cholesterol goals and if it's practical to use in real clinics.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Johns Hopkins University School of Medicine

    RECRUITING

    Baltimore, Maryland, 21287, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Corrie Lipids Digital Health Program (smartphone app and clinician education)

What this could lead to

If successful, this program could offer a practical, scalable way to help more people manage their cholesterol and reduce heart disease risk.

What could go wrong

This is an early-stage implementation study, not a drug trial. Success depends on people actually using the app and clinicians adopting it, which may not happen consistently.

Conditions

The condition(s) this trial relates to.

atherosclerotic cardiovascular disease diabetes mellitus familial hypercholesterolemia hyperlipidemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.